Literature DB >> 7332012

Surrogate mothers: the legal issues.

T M Mady.   

Abstract

Increasing numbers of couples have benefitted from, or may be considering use of, the surrogate mother procedure. In this procedure, a couple, usually a husband and wife, enters into a contract with a surrogate mother. Under the terms of the contract, the surrogate mother is artificially inseminated, bears a child, and relinquishes all rights regarding that child to the semen donor and his wife. In exchange for bearing a child, the surrogate mother often receives a fee. In light of such increased use of the procedure, the issue of whether or not the arrangement is legal has particular importance. Questions of legality involve possible violations of criminal baby-selling statutes. Issues of whether adoption is necessary and whether the child is legitimate also are inherent in the surrogate mother arrangement. This Note argues that these questions should be resolved in favor of finding no impediment to the use of the surrogate mother procedure, at least within certain guidelines. However, even in the absence of legal impediment, detailed contracts and thorough medical screening for genetic, physical and psychological problems would further eliminate ambiguities regarding liability. In addition, the Note concludes that legislation should be enacted to deal with the legal ambiguities of the surrogate mother arrangement. This legislation should regulate the parties that enter into such an arrangement and the rights and responsibilities of these parties.

Entities:  

Keywords:  Genetics and Reproduction; Legal Approach

Mesh:

Year:  1981        PMID: 7332012

Source DB:  PubMed          Journal:  Am J Law Med        ISSN: 0098-8588


  2 in total

1.  Womb for rent: ethical aspects of surrogate motherhood.

Authors:  S Bhimji
Journal:  CMAJ       Date:  1987-12-15       Impact factor: 8.262

2.  Building Irish families through surrogacy: medical and judicial issues for the advanced reproductive technologies.

Authors:  Eric Scott Sills; Clifford M Healy
Journal:  Reprod Health       Date:  2008-11-04       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.